Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1 3Phase NA 1Phase 4 1Phase 1/2 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

NETWORK 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Prostatic Neoplasms 6Lymphoma 6Burkitt Lymphoma 4Leukemia, Biphenotypic, Acute 3Anemia, Refractory, with Excess of Blasts 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory 2Prostate Cancer Metastatic 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lipomatosis, Multiple Symmetrical 1Lipoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Cardiotoxicity 1

Interventions

Methotrexate 7Cyclophosphamide 7Methylprednisolone 6merphos 5Cytarabine 5Asparaginase 5pegaspargase 4Vincristine 4Specimen Handling 4Mercaptopurine 4Leucovorin 4Dexamethasone 4Daunorubicin 4dexamethasone acetate 3dexamethasone 21-phosphate 3calaspargase pegol 3azathiopurine 3auricularum 3Thioguanine 3Prednisolone 3Hydrocortisone 3Etoposide 3Doxorubicin 3Calcium Dobesilate 3Antilymphocyte Serum 3prednylidene 2liposomal amphotericin B 2exifone 2deltacortene 2blinatumomab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Biphenotypic, Acute × Hydrocortisone × Clear all
NCT03007147 2026-05-04

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Active not recruiting
475 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00557193 2024-07-15

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Completed
218 enrolled 21 charts
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003728 2011-01-21

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
1,500 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡